Biotricity (NASDAQ:BTCY) Trading Down 1.4% – Time to Sell?

Biotricity, Inc. (NASDAQ:BTCY) shares were down 1.4% on Tuesday . The company traded as low as $0.2282 and last traded at $0.2464. Approximately 5,677 shares traded hands during mid-day trading, a decline of 89% from the average daily volume of 52,292 shares. The stock had previously closed at $0.2499.

Biotricity Stock Performance

The firm’s 50 day moving average price is $0.26 and its 200-day moving average price is $0.41. The firm has a market capitalization of $7.15 million, a PE ratio of -0.23 and a beta of 1.36.

Biotricity (NASDAQ:BTCY) last announced its quarterly earnings results on Wednesday, February 11th. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.04. The business had revenue of $3.99 million during the quarter. On average, equities research analysts expect that Biotricity, Inc. will post -0.67 earnings per share for the current fiscal year.

About Biotricity

Biotricity, Inc (NASDAQ:BTCY) is a digital health company specializing in remote patient monitoring solutions across cardiovascular and chronic disease management. The firm develops and commercializes a patented wearable biosensor platform designed to capture continuous physiological data, including electrocardiogram (ECG) readings and heart rate variability. This integrated system combines lightweight, adhesive biosensors with cloud-based analytics and clinician-facing software to support early detection of cardiac arrhythmias and facilitate telehealth care delivery.

The company’s flagship offering, the Bioflux™ platform, comprises a small, single-use wearable device that transmits real-time data to a secure portal, where advanced algorithms analyze cardiac patterns and generate clinician alerts.